GGrantIndex
Sort

3,198 grants matching mrna vaccine

Specific Pathogen Free Baboon Research Resource (SPFBRR) - Administrative Supplement

$499,948
Joe H. Simmons · University Of Tx Md Anderson Can Ctr · P40 · FY2021 · OD

Chemical intervention of influenza virus RNA nuclear export

$499,523
Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · R33 · FY2018 · AI

Manufacturing and Characterization of Potent mRNA Lipid Nanoparticle Vaccines at Multiple Scales

$498,998
Mikell Paige · George Mason University · R01 · FY2021 · FD

Manufacturing and Characterization of Potent mRNA Lipid Nanoparticle Vaccines at Multiple Scales

$498,828
Mikell Paige · George Mason University · R01 · FY2023 · FD

Enhancing HIV-1 vaccines by altering vaccine dose

$498,659
Pablo Penaloza · Northwestern University At Chicago · R56 · FY2024 · AI

Modulation of Viral Antigen Presentation in the Lung

$498,316
Anna Karolina Palucka · Jackson Laboratory · U19 · FY2021 · AI

Modulation of Lung Immune Responses to Viral Infection

$498,316
Anna Karolina Palucka · Jackson Laboratory · U19 · FY2021 · AI

Messenger RNA capping and methylation in pneumoviruses

$498,053
Jianrong Li · Ohio State University · R01 · FY2019 · AI

Innate Immunity

$497,680
Bali Pulendran · Emory University · U19 · FY2017 · AI

Viral RNA Modifying Enzymes

$497,234
Stewart H Shuman · Sloan-Kettering Inst Can Research · R01 · FY2010 · GM

Next-generation PEGylation: antifouling and immunoevasive semi-randomized zwitterionic peptides

$496,982
Danielle Benoit · University Of Oregon Eugene · · FY2023 · MPS

Receptor Mediated T and B Cell Activation

$496,200
Richard J. Hodes · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA

Human-informed data-driven development of next-generation T cell vaccine against malaria

$495,904
Denise L. Doolan · James Cook University Of No Queensland · R01 · FY2022 · AI

Transitional and Naive CD4 T cells and B cells in Infant Vaccine Responses

$494,630
David Bram Lewis · Stanford University · R01 · FY2015 · AI

Scientific Core Two

$493,694
Marie Pancera · Fred Hutchinson Cancer Center · U19 · FY2024 · AI

Mucosal Immunity and Influenza Vaccines: Phenotype and Role of Activated B Cells

$491,771
Eugene C Butcher · Palo Alto Veterans Instit For Research · RC1 · FY2010 · AI

Manufacturing and Characterization of Potent mRNA Lipid Nanoparticle Vaccines at Multiple Scales

$491,446
Mikell Paige · George Mason University · R01 · FY2022 · FD

Viral RNA Modifying Enzymes

$491,136
Stewart H Shuman · Sloan-Kettering Inst Can Research · R01 · FY2009 · GM

Coordination of metabolism and virulence during infection

$490,602
Brian M Ahmer · Ohio State University · R01 · FY2014 · AI

Cost-Effective Manufacturing of Pharmaceutical mRNA

$489,822
Emmanuel Labourier · Ambion Diagnostics, Inc. · R44 · FY2006 · GM

Determinants of resistance in human schistosomiasis

$488,395
Daniel G Colley · University Of Georgia · R01 · FY2007 · AI

Determinants of resistance in human schistosomiasis

$488,332
Daniel G Colley · University Of Georgia · R01 · FY2006 · AI

Human-informed data-driven development of next-generation T cell vaccine against malaria

$487,101
Denise L. Doolan · University Of Queensland · R01 · FY2023 · AI

A multipronged, mRNA gene therapy approach to HIV cure

$486,057
Edward Kreider · University Of Pennsylvania · DP2 · FY2025 · AI

COVID-19 Sample Collection and Vaccine Studies

$485,881
Julie E. Ledgerwood · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI